期刊文献+

肝移植术后急性肾功能衰竭的危险因素分析 被引量:1

下载PDF
导出
摘要 肝移植术已成为治疗终末期肝病的有效手段,而急性肾功能衰竭(ARF)是肝移植术后早期常见的并发症之一,发生率为12%~70%。原位肝移植后肾功能可能受损害,主要有以下因素引起:术前肾功能障碍;术中肾低灌注;术后急性疾病状态,如任何原因引起的移植物功能衰竭或脓毒症;运用肾毒性药物。ARF是肝移植术后立即发生的一种并发症,可影响到患者的预后并引起较高的死亡率。因此,研究其病因具有非常重要的意义,本文对此作一简要报道。
作者 赵文华 穆红
出处 《国际检验医学杂志》 CAS 2009年第6期623-624,共2页 International Journal of Laboratory Medicine
  • 相关文献

参考文献18

  • 1Chuang FR, Lin CC, Wang PH, et al. Acute renal failure after cadaveric related liver transplantation [J]. Transplant Proc, 2004, 36(8) :2328-2330.
  • 2Rimol A, Gavaler JS, Sehade RR, et al. Effects of renal impairment on liver transplantation[J]. Gastroenterol, 1997,93 : 148-156.
  • 3Andres A, Morales JM, Farias J, et al. Acute renal failure after liver transplantation in patients treated with cyclosporine[J].Transplant Proc, 1992, 24(1) :1267.
  • 4Markmann JF, Markmann JW, Markmann DA, et al. Preoperative factors associated with outcome and their impact on resource use in 1148 consecutive primary liver transplants[J]. Transplantation, 2004, 72(6):1113 -1122.
  • 5Lima EQ, Zanetta DM, Castro I, et al. Risk factors for development of acute renal failure after liver transplantation[J]. Renal Failure, 2003, 25(4) :553-560.
  • 6Chuang FR, Lin CC, Wang PH, et al. Acute renal failure after eadaverie related liver transplantation [J]. Transplant Proe, 2004, 36(8) :2328-2330.
  • 7Chen G, Dong JH, He Y. Mechanism and treatment of acute renal failure after liver transplantation[J]. Zhonghua Putong Waike Zazhi, 2004, 17(4):254-256.
  • 8钱叶本,陈规划,黄洁夫.肝移植患者术后早期死亡原因分析[J].中华器官移植杂志,2002,23(3):161-163. 被引量:30
  • 9张欢,乔青,杨拔贤,孙颖,赵欣,马瑞云,苟淑琴,张秀华.前列腺素E_1与多巴胺对肝移植术患者术中肾功能的影响[J].中华麻醉学杂志,2005,25(1):15-18. 被引量:7
  • 10Alvares-da-silva MR,Waechter FL,Francisconi CF, et al. Risk factors for postoperative acute renal failure at a new orthotopic liver transplantation program[J]. Transplant Proc, 2005, 31 (7) : 3050-3052.

二级参考文献42

  • 1Grande L, Rimo1a A, Cugat E, et al. Effect of venovenous bypass on perioperative renal function in liver transplantation: results of a randomized, controlled trial. Hepatology, 1996,23:1418-1428.
  • 2Papadakis MA, Arieff AI. Unpredictability of clinical evaluation of renal function in cirrhosis: a prospective study. Am J Med, 1987,82:945-952.
  • 3Bellomo R, Chapman M, Finfer S, et al. Low-dose dopamine in patients with early renal dysfunction: a placebo-controlled randomized trial.Australian and New Zealnad Intersive Care Society (ANZICS) Clinical Trials Group. Lancet, 2000,356: 2139-2143.
  • 4Galley HF. Renal-dose dopamine: will the message now get through.? Lancet ,2000,356:2112-2113.
  • 5Ludwig K, Walter H. Hepatorenai syndrome. Semin nephrol, 2002,22(4) :290
  • 6Fukuda Y. Renal glomerular changes associated with liver cirrhosis. Acta Pathol Jpn, 1982, 32:561
  • 7D' Amico G. Renal involvement in hepatitis C infection: Cryoglobulinenic glomerulonephritis. Kidney Int, 1998,54:650
  • 8Lomax-Smith JD, Zabrowarny LA, Howarth GS, et al. The immunological characterization of mesangial IgA deposits. Am J Pathol, 1983,113: 359
  • 9Roccatello D, Picciotto G, Torchio M, et al. Removal systems of immunoglobulin A and immunoglobulin A containing complexes in IgA nephropathy and cirrhosis patients. Lab Invest, 1993,69:714
  • 10Skogh T, Blomhoff R, Eskild W, et al. Hepatic uptake of circulation IgG immune complexes. Immunology, 1985: 55: 585

共引文献74

同被引文献11

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部